The first once-weekly basal insulin approved in the United States is now stocked at more than 70,000 pharmacies, and the most important thing for a patient starting it is not the convenience. It is the concentration.
Insulin Icodec-Abae, sold as Awiqli, is formulated at 700 units/mL. Standard long-acting insulins such as glargine are U-100. That is a sevenfold difference in strength sitting in the same refrigerator, in a pen that looks broadly similar to the ones a household may already have.
